Skip to content
Topics
Stories

China seeks to become major global vaccine player in wake of Covid-19 pandemic

People in this story

Photo by Matthew Modoono/Northeastern University
Thomas Matta, an assistant clinical professor, and members of the National Guard fill Pfizer vaccines inside Florian Hall in Dorchester, Massachusetts on March 12, 2021.

South China Morning Post, April 2021

China is trying to reshape its pharmaceutical industry and take on an unprecedented role as a major vaccine supplier to the rest of the world in light of the ongoing Covid-19 pandemic. It aims to produce enough doses to vaccinate 70 per cent of the country’s population, or 980 million people, and the same amount for export by the end of the year, according to Feng Duojia, president of China Association for Vaccines. By March, more than 100 million doses had been exported, about the same as the combined exports from India and the European Union.

Feng said the target is to produce 5 billion doses of Covid-19 by the end of next year. The figure is about 10 times its total vaccine output before the start of the pandemic – in 2019 the Chinese drug regulator signed off 528 million doses of domestic vaccines. “China is building 18 production lines and each large-scale production line is like building a new China National Biotec Group,” Feng said, referring to the dominant player in the national vaccine making industry.Biotec, a subsidiary of the state-owned China National Pharmaceutical Group (Sinopharm), and Sinovac have produced 250 million doses of Covid-19 vaccines which have been administered in China and overseas.

Continue reading at South China Morning Post.

More Stories

Celtics often at epicenter of sports, racial issues in Boston

10.25.2021

Woman arrested in slayings of 4 people in central Michigan

10.21.2021

How the US fails to take away guns from domestic abusers: ‘these deaths are preventable’

10.26.21
In the News